IPSC – century therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at Chardan Capital from $17.00 to $11.00. They now have a "buy" rating on the stock.
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at HC Wainwright from $9.00 to $5.00. They now have a "buy" rating on the stock.
Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Form SC 13G/A Century Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
Form SC 13G/A Century Therapeutics, Filed by: Casdin Capital, LLC
Form SC 13G/A Century Therapeutics, Filed by: FMR LLC
Form 4 Century Therapeutics, For: Nov 01 Filed by: Carr Douglas
Form 4 Century Therapeutics, For: Nov 04 Filed by: Farid Adrienne
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.